Home › Companies › REVANCE THERAPEUTICS INC. › 2023-2024

REVANCE THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated November 7, 2026.

  • 7Reported items
  • 192Asset managers
  • 911Fund votes
  • May 1, 2024Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from REVANCE THERAPEUTICS INC. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024

Explore REVANCE THERAPEUTICS INC. in the interactive database Compare manager voting policies

How asset managers voted at the REVANCE THERAPEUTICS INC. 2023-2024 meeting

Each item below shows how the 192 asset managers that disclosed a REVANCE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of REVANCE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Election of Directors: Angus C. Russell

No official resultsDIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

96% of fund votes cast · no official result

FOR
Details: votes by 53 asset managers

The 53 asset managers below reported 30,238,974 for, 1,416,971 withheld, 202,532 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 30,238,974ABSTAIN: 202,532WITHHOLD: 1,416,971
Largest asset managers voting on “Election of Directors: Angus C. Russell” at REVANCE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capital Group7,384,1920 00For
NEW ECONOMY FUND6,334,3830 00For
Vanguard4,734,1110 00For
FRANKLIN STRATEGIC SERIES3,030,7520 00For
BlackRock2,773,9000 00For
JPMorgan1,739,3930 00For
Federated Hermes1,388,5800 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)00 0775,832Withhold
Charles Schwab703,4770 00For
Fidelity278,7900 00For
VALUE LINE CAPITAL APPRECIATION FUND INC274,2050 00For
AIG/SunAmerica00 0254,033Withhold
MUTUAL FUND SERIES TRUST245,0000 00For
TIAA243,4560 00For
State Street238,6060 0321For
Equitable139,2040 088,800Mixed
Jackson National00 169,9810Abstain
Columbia Threadneedle161,5400 00For
QUANTITATIVE MASTER SERIES LLC154,2150 00For
Lincoln Financial71,1000 039,377Mixed
Nushares ETF Trust100,0010 00For
ProShares00 056,109Withhold
SEI46,5690 00For
Northern Trust38,9480 00For
Global X35,8310 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

2. Election of Directors: Olivia C. Ware

No official resultsDIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

96% of fund votes cast · no official result

FOR
Details: votes by 53 asset managers

The 53 asset managers below reported 30,296,190 for, 1,359,755 withheld, 202,532 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 30,296,190ABSTAIN: 202,532WITHHOLD: 1,359,755
Largest asset managers voting on “Election of Directors: Olivia C. Ware” at REVANCE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capital Group7,384,1920 00For
NEW ECONOMY FUND6,334,3830 00For
Vanguard4,734,1110 00For
FRANKLIN STRATEGIC SERIES3,030,7520 00For
BlackRock2,773,9000 00For
JPMorgan1,739,3930 00For
Federated Hermes1,388,5800 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)00 0775,832Withhold
Charles Schwab703,4770 00For
Fidelity278,7900 00For
VALUE LINE CAPITAL APPRECIATION FUND INC274,2050 00For
AIG/SunAmerica00 0254,033Withhold
MUTUAL FUND SERIES TRUST245,0000 00For
TIAA243,4560 00For
State Street238,6060 0321For
Equitable139,2040 088,800Mixed
Jackson National00 169,9810Abstain
Columbia Threadneedle161,5400 00For
QUANTITATIVE MASTER SERIES LLC154,2150 00For
Lincoln Financial71,1000 039,377Mixed
Nushares ETF Trust100,0010 00For
ProShares00 056,109Withhold
SEI46,5690 00For
Northern Trust38,9480 00For
Global X35,8310 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

3. Election of Directors: Julian S. Gangolli

No official resultsDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.6% of fund votes cast · no official result

FOR
Details: votes by 52 asset managers

The 52 asset managers below reported 31,516,570 for, 96,907 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 31,516,570WITHHOLD: 96,907
Largest asset managers voting on “Election of Directors: Julian S. Gangolli” at REVANCE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capital Group7,384,1920 00For
NEW ECONOMY FUND6,334,3830 00For
Vanguard4,734,1110 00For
FRANKLIN STRATEGIC SERIES3,030,7520 00For
BlackRock2,773,9000 00For
JPMorgan1,739,3930 00For
Federated Hermes1,388,5800 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)775,8320 00For
Charles Schwab703,4770 00For
Fidelity278,7900 00For
VALUE LINE CAPITAL APPRECIATION FUND INC274,2050 00For
AIG/SunAmerica254,0330 00For
TIAA243,4560 00For
State Street238,9160 011For
Equitable139,2040 088,800Mixed
Jackson National169,9810 00For
Columbia Threadneedle161,5400 00For
QUANTITATIVE MASTER SERIES LLC154,2150 00For
Lincoln Financial110,4770 00For
Nushares ETF Trust100,0010 00For
ProShares56,1090 00For
SEI46,5690 00For
Northern Trust38,9480 00For
Global X35,8310 00For
New York Life34,3190 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

4. Approval of, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy…

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

81% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: description as filed, votes by 184 asset managers

Description as filed by funds: Approval of, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement..

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 53 asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers as disclosed in ” at REVANCE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capital Group7,384,1920 00For
NEW ECONOMY FUND6,334,3830 00For
Vanguard4,734,1110 00For
FRANKLIN STRATEGIC SERIES03,030,752 00Against
BlackRock2,773,9000 00For
JPMorgan01,739,393 00Against
Federated Hermes1,388,5800 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)0775,832 00Against
Charles Schwab703,4770 00For
Fidelity278,7900 00For
VALUE LINE CAPITAL APPRECIATION FUND INC0274,205 00Against
AIG/SunAmerica254,0330 00For
TIAA243,4560 00For
State Street238,90225 00For
Equitable228,0040 00For
Jackson National0169,981 00Against
Columbia Threadneedle161,5400 00For
QUANTITATIVE MASTER SERIES LLC154,2150 00For
Lincoln Financial110,4770 00For
Nushares ETF Trust100,0010 00For
ProShares56,1090 00For
SEI046,569 00Against
Northern Lights Fund Trust IV39,5850 00For
Northern Trust38,9480 00For
Global X035,831 00Against

Fund voting reports, all 53 managers: 25,467,122 for, 6,177,844 against, 8,096 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 148 asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers as disclosed in ” at REVANCE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capital Group13,945,5350 00For
FRANKLIN ADVISERS INC39,3776,143,419 00Against
Palo Alto Investors LP5,237,2840 00For
Polar Capital Holdings Plc3,873,1690 00For
BlackRock2,476,57418,505 00For
Rubric Capital Management LP1,675,1340 00For
CIBC Asset Management Inc1,667,1180 00For
State Street1,449,806452 00For
Federated Hermes1,391,9770 00For
BAMCO INC /NY/0945,813 00Against
SUVRETTA CAPITAL MANAGEMENT, LLC800,0000 00For
Northern Trust766,6086,716 00For
Charles Schwab703,5400 00For
PERCEPTIVE ADVISORS LLC600,0000 00For
RICE HALL JAMES & ASSOCIATES, LLC10,126552,901 00Against
HighTower Advisors, LLC406,9270 00For
Nuveen350,9740 00For
UBS174,667134,306 00Mixed
BLAIR WILLIAM & CO/IL292,7730 00For
SCHRODER INVESTMENT MANAGEMENT GROUP0288,726 00Against
MARSHALL WACE, LLP0239,125 00Against
GEODE CAPITAL MANAGEMENT, LLC236,7430 00For
Vanguard234,0760 00For
MELLON INVESTMENTS Corp145,0070 00For
JPMorgan8,644128,255 00Mixed

Institutional-manager reports, all 148 managers: 38,064,065 for, 9,093,579 against, 6,623 withheld, 9,000 not voted. Showing the 25 largest; see all in the interactive database.

5. To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTESCOMPENSATION

Combines 2 wordings of this item as funds reported it.

48.2% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: votes by 5 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 1 asset manager voting on “To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy ” at REVANCE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST0245,000 00Against

Fund voting reports, all 1 managers: 245,000 against.

Institutional-manager reports: 3 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy ” at REVANCE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Opaleye Management Inc.228,0000 00For
Orion Porfolio Solutions, LLC220 00For
Orion Portfolio Solutions, LLC220 00For

Institutional-manager reports, all 3 managers: 228,044 for.

6. Advisory Vote to Ratify Named Executive Officers' Compensation

No official resultsSECTION 14A SAY-ON-PAY VOTES

0.5% of fund votes cast · no official result

AGAINST
Details: votes by 4 asset managers

The 4 asset managers below reported 9,828 for, 2,294,574 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,828AGAINST: 2,294,574
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at REVANCE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
JPMorgan02,016,562 00Against
DCF Advisers, LLC0263,372 00Against
ALGERT GLOBAL LLC014,640 00Against
ESSEX INVESTMENT MANAGEMENT CO LLC9,8280 00For

7. Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting…

No official resultsAUDIT-RELATED

Combines 4 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 54 asset managers

Description as filed by funds: Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

The 54 asset managers below reported 31,645,047 for, 29 against, 8,096 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 31,645,047AGAINST: 29ABSTAIN: 8,096
Largest asset managers voting on “Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public acc” at REVANCE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capital Group7,384,1920 00For
NEW ECONOMY FUND6,334,3830 00For
Vanguard4,734,1110 00For
FRANKLIN STRATEGIC SERIES3,030,7520 00For
BlackRock2,773,9000 00For
JPMorgan1,739,3930 00For
Federated Hermes1,388,5800 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)775,8320 00For
Charles Schwab703,4770 00For
Fidelity278,7900 00For
VALUE LINE CAPITAL APPRECIATION FUND INC274,2050 00For
AIG/SunAmerica254,0330 00For
TIAA243,4560 00For
State Street238,89829 00For
Equitable228,0040 00For
Jackson National169,9810 00For
Columbia Threadneedle161,5400 00For
QUANTITATIVE MASTER SERIES LLC154,2150 00For
Lincoln Financial110,4770 00For
Nushares ETF Trust100,0010 00For
ProShares56,1090 00For
SEI46,5690 00For
Northern Lights Fund Trust IV39,5850 00For
Northern Trust38,9480 00For
Global X35,8310 00For

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

Largest REVANCE THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.

Fund voting reports: top REVANCE THERAPEUTICS INC. shareholders by shares voted on “Approval of, on an advisory basis, the compensation of the Company's named executive officers…”, 2023-2024
#Asset manager Shares voted
1Capital Group 7,384,192
2NEW ECONOMY FUND 6,334,383
3Vanguard 4,734,111
4FRANKLIN STRATEGIC SERIES 3,030,752
5BlackRock 2,773,900
6JPMorgan 1,739,393
7Federated Hermes 1,388,580
8BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) 775,832
9Charles Schwab 703,477
10Fidelity 278,790
Institutional-manager reports: top REVANCE THERAPEUTICS INC. shareholders by shares voted on “Approval of, on an advisory basis, the compensation of the Company's named executive officers…”, 2023-2024
#Asset manager Shares voted
1Capital Group 13,945,535
2FRANKLIN ADVISERS INC 6,182,796
3Palo Alto Investors LP 5,237,284
4Polar Capital Holdings Plc 3,873,169
5BlackRock 2,495,079
6Rubric Capital Management LP 1,675,134
7CIBC Asset Management Inc 1,667,118
8State Street 1,450,258
9Federated Hermes 1,391,977
10BAMCO INC /NY/ 945,813

Shown as share counts, not percentages: no shares-outstanding figure has been matched to REVANCE THERAPEUTICS INC. for the 2023-2024 season, so there is no denominator to divide by.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 7, 2026; a live search always shows the current data.

At REVANCE THERAPEUTICS INC.'s shareholder meeting held May 1, 2024, in the 2023-2024 proxy season, 192 asset managers reported how they voted in their SEC Form N-PX filings, covering 911 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — Approval of, on an advisory basis, the compensation of the Company's named executive officers… — the reporting funds and managers cast 81% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

REVANCE THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page).

Download data (CSV): ballot items · votes by manager · column guide.